{"entity":{"type":"insider","cik":"0001375124","url":"/insider/0001375124","json_url":"/insider/0001375124.json","name":"Perkins Adelene Q","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":101,"n_filings":20,"first":"2007-05-07","last":"2023-09-12","span_basis":"filed_date"},"name_variants":[{"name":"Perkins Adelene Q","source":"filing","n_filings":20,"first_seen":"2007-05-07","last_seen":"2023-09-12"}],"transactions":[{"id":8309854,"accession":"0000899243-23-018762","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-018762","line_url":"/filing/0000899243-23-018762#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":410196.0,"shares_display":"410,196","price_per_share":0.07,"price_display":"0.07","price_state":"stated","total_value":28713.72,"total_display":"28,713.72","total_whole":"28,714","shares_owned_after":1175291.0,"shares_owned_after_display":"1,175,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-12","scope":"insider"},{"id":6773521,"accession":"0000899243-18-025797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-025797","line_url":"/filing/0000899243-18-025797#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":2.82,"price_display":"2.82","price_state":"stated","total_value":14100.0,"total_display":"14,100.00","total_whole":"14,100","shares_owned_after":609561.0,"shares_owned_after_display":"609,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-02","scope":"insider"},{"id":6062239,"accession":"0000899243-18-006636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-006636","line_url":"/filing/0000899243-18-006636#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":2.778,"price_display":"2.78","price_state":"stated","total_value":13890.0,"total_display":"13,890.00","total_whole":"13,890","shares_owned_after":607252.0,"shares_owned_after_display":"607,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-07","scope":"insider"},{"id":8785889,"accession":"0001209191-15-056813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-056813","line_url":"/filing/0001209191-15-056813#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.93,"price_display":"10.93","price_state":"stated","total_value":54650.0,"total_display":"54,650.00","total_whole":"54,650","shares_owned_after":359432.0,"shares_owned_after_display":"359,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-25","filed_date":"2015-06-26","scope":"insider"},{"id":8130336,"accession":"0001209191-15-047509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-047509","line_url":"/filing/0001209191-15-047509#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.81,"price_display":"12.81","price_state":"stated","total_value":128100.0,"total_display":"128,100.00","total_whole":"128,100","shares_owned_after":364432.0,"shares_owned_after_display":"364,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-27","filed_date":"2015-05-28","scope":"insider"},{"id":8925535,"accession":"0001209191-15-043349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-043349","line_url":"/filing/0001209191-15-043349#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.18,"price_display":"12.18","price_state":"stated","total_value":121800.0,"total_display":"121,800.00","total_whole":"121,800","shares_owned_after":374432.0,"shares_owned_after_display":"374,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-14","filed_date":"2015-05-15","scope":"insider"},{"id":8185246,"accession":"0001209191-15-027167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-027167","line_url":"/filing/0001209191-15-027167#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":320000.0,"total_display":"320,000.00","total_whole":"320,000","shares_owned_after":384432.0,"shares_owned_after_display":"384,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-17","scope":"insider"},{"id":8598092,"accession":"0001209191-15-024178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-024178","line_url":"/filing/0001209191-15-024178#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":412500.0,"total_display":"412,500.00","total_whole":"412,500","shares_owned_after":404432.0,"shares_owned_after_display":"404,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-09","scope":"insider"},{"id":9269517,"accession":"0001209191-15-024177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-024177","line_url":"/filing/0001209191-15-024177#line-1","is_derivative":false,"issuer_cik":"0001375124","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001375124","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.8268,"price_display":"14.83","price_state":"stated","total_value":296536.0,"total_display":"296,536.00","total_whole":"296,536","shares_owned_after":429432.0,"shares_owned_after_display":"429,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-29","filed_date":"2015-03-09","scope":"insider"},{"id":8572665,"accession":"0001209191-15-008212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-008212","line_url":"/filing/0001209191-15-008212#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.8268,"price_display":"14.83","price_state":"stated","total_value":296536.0,"total_display":"296,536.00","total_whole":"296,536","shares_owned_after":427535.0,"shares_owned_after_display":"427,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-29","filed_date":"2015-02-02","scope":"insider"},{"id":4738064,"accession":"0001181431-13-049008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-049008","line_url":"/filing/0001181431-13-049008#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (Pres & Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13076.0,"shares_display":"13,076","price_per_share":20.5029,"price_display":"20.50","price_state":"stated","total_value":268095.9204,"total_display":"268,095.92","total_whole":"268,096","shares_owned_after":447535.0,"shares_owned_after_display":"447,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-13","filed_date":"2013-09-13","scope":"insider"},{"id":4738057,"accession":"0001181431-13-049008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-049008","line_url":"/filing/0001181431-13-049008#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (Pres & Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31924.0,"shares_display":"31,924","price_per_share":20.8116,"price_display":"20.81","price_state":"stated","total_value":664389.5184,"total_display":"664,389.52","total_whole":"664,390","shares_owned_after":460611.0,"shares_owned_after_display":"460,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-12","filed_date":"2013-09-13","scope":"insider"},{"id":7287163,"accession":"0001181431-10-062359","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-062359","line_url":"/filing/0001181431-10-062359","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (Pres & Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":6.102764,"price_display":"6.10","price_state":"stated","total_value":152569.1,"total_display":"152,569.10","total_whole":"152,569","shares_owned_after":305729.0,"shares_owned_after_display":"305,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-16","filed_date":"2010-12-17","scope":"insider","n_lines":3},{"id":7159483,"accession":"0001181431-10-044330","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-044330","line_url":"/filing/0001181431-10-044330#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (Pres & Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5349.0,"shares_display":"5,349","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":26691.51,"total_display":"26,691.51","total_whole":"26,692","shares_owned_after":291538.0,"shares_owned_after_display":"291,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-25","filed_date":"2010-08-26","scope":"insider"},{"id":7159481,"accession":"0001181431-10-044330","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-044330","line_url":"/filing/0001181431-10-044330#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Director, Officer (Pres & Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44651.0,"shares_display":"44,651","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":218343.39,"total_display":"218,343.39","total_whole":"218,343","shares_owned_after":286189.0,"shares_owned_after_display":"286,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-24","filed_date":"2010-08-26","scope":"insider"},{"id":2714052,"accession":"0001181431-08-068162","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001181431-08-068162","line_url":"/filing/0001181431-08-068162","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (Pres & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Pres & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8500.0,"shares_display":"8,500","price_per_share":7.945310588235294,"price_display":"7.95","price_state":"stated","total_value":67535.14,"total_display":"67,535.14","total_whole":"67,535","shares_owned_after":241538.0,"shares_owned_after_display":"241,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-17","filed_date":"2008-12-18","scope":"insider","n_lines":12},{"id":2713981,"accession":"0001181431-08-068162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-068162","line_url":"/filing/0001181431-08-068162","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (Pres & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Pres & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":7.411428571428571,"price_display":"7.41","price_state":"stated","total_value":5188.0,"total_display":"5,188.00","total_whole":"5,188","shares_owned_after":232938.0,"shares_owned_after_display":"232,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-16","filed_date":"2008-12-18","scope":"insider","n_lines":2},{"id":3368535,"accession":"0001181431-08-064271","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-08-064271","line_url":"/filing/0001181431-08-064271#line-6","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (Pres & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Pres & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.7,"price_display":"5.70","price_state":"stated","total_value":570.0,"total_display":"570.00","total_whole":"570","shares_owned_after":232338.0,"shares_owned_after_display":"232,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-25","filed_date":"2008-11-26","scope":"insider"},{"id":3368533,"accession":"0001181431-08-064271","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-08-064271","line_url":"/filing/0001181431-08-064271","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (Pres & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Pres & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21941.0,"shares_display":"21,941","price_per_share":6.163094207192015,"price_display":"6.16","price_state":"stated","total_value":135224.45,"total_display":"135,224.45","total_whole":"135,224","shares_owned_after":229238.0,"shares_owned_after_display":"229,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-24","filed_date":"2008-11-26","scope":"insider","n_lines":5},{"id":2692269,"accession":"0001181431-08-019510","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-08-019510","line_url":"/filing/0001181431-08-019510","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":776.0,"shares_display":"776","price_per_share":5.905798969072165,"price_display":"5.91","price_state":"stated","total_value":4582.9,"total_display":"4,582.90","total_whole":"4,583","shares_owned_after":209947.0,"shares_owned_after_display":"209,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-17","filed_date":"2008-03-18","scope":"insider","n_lines":3},{"id":7345227,"accession":"0001181431-07-040712","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-07-040712","line_url":"/filing/0001181431-07-040712","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":10.6395,"price_display":"10.64","price_state":"stated","total_value":106395.0,"total_display":"106,395.00","total_whole":"106,395","shares_owned_after":209521.0,"shares_owned_after_display":"209,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-15","filed_date":"2007-06-18","scope":"insider","n_lines":3},{"id":7829400,"accession":"0001181431-07-031773","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001181431-07-031773","line_url":"/filing/0001181431-07-031773#line-12","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":10.9,"price_display":"10.90","price_state":"stated","total_value":16350.0,"total_display":"16,350.00","total_whole":"16,350","shares_owned_after":199521.0,"shares_owned_after_display":"199,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-11","filed_date":"2007-05-11","scope":"insider"},{"id":7829397,"accession":"0001181431-07-031773","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001181431-07-031773","line_url":"/filing/0001181431-07-031773#line-11","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":646.0,"shares_display":"646","price_per_share":10.8,"price_display":"10.80","price_state":"stated","total_value":6976.8,"total_display":"6,976.80","total_whole":"6,977","shares_owned_after":197621.0,"shares_owned_after_display":"197,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-11","filed_date":"2007-05-11","scope":"insider"},{"id":7829394,"accession":"0001181431-07-031773","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-07-031773","line_url":"/filing/0001181431-07-031773#line-10","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":2184.0,"total_display":"2,184.00","total_whole":"2,184","shares_owned_after":196875.0,"shares_owned_after_display":"196,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-11","filed_date":"2007-05-11","scope":"insider"},{"id":7829392,"accession":"0001181431-07-031773","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001181431-07-031773","line_url":"/filing/0001181431-07-031773#line-9","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":10.85,"price_display":"10.85","price_state":"stated","total_value":2170.0,"total_display":"2,170.00","total_whole":"2,170","shares_owned_after":197821.0,"shares_owned_after_display":"197,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-11","filed_date":"2007-05-11","scope":"insider"},{"id":7829389,"accession":"0001181431-07-031773","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-07-031773","line_url":"/filing/0001181431-07-031773#line-8","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":10.91,"price_display":"10.91","price_state":"stated","total_value":1091.0,"total_display":"1,091.00","total_whole":"1,091","shares_owned_after":198021.0,"shares_owned_after_display":"198,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-11","filed_date":"2007-05-11","scope":"insider"},{"id":7829386,"accession":"0001181431-07-031773","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-07-031773","line_url":"/filing/0001181431-07-031773#line-7","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":1087.0,"total_display":"1,087.00","total_whole":"1,087","shares_owned_after":196675.0,"shares_owned_after_display":"196,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-11","filed_date":"2007-05-11","scope":"insider"},{"id":7829383,"accession":"0001181431-07-031773","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-07-031773","line_url":"/filing/0001181431-07-031773#line-6","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001375124","owner_name":"Perkins Adelene Q","owner_display_name":"Perkins Adelene Q","owner_url":"/insider/0001375124","role":"Officer (EVP and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":10.82,"price_display":"10.82","price_state":"stated","total_value":1082.0,"total_display":"1,082.00","total_whole":"1,082","shares_owned_after":196975.0,"shares_owned_after_display":"196,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-11","filed_date":"2007-05-11","scope":"insider"}],"collapsed":true,"next_cursor":"2007-05-11|7829383","ledger_fault":false,"count":{"value":101,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":89,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":101},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001113148","name":"INFINITY PHARMACEUTICALS, INC.","url":"/issuer/0001113148","role":"Director, Officer (Chief Executive Officer)","n_filings":20,"first_seen":"2007-05-07","last_seen":"2023-09-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001375124","retrieved_at":"2026-08-23T07:06:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}